Format

Send to

Choose Destination
Can J Physiol Pharmacol. 2015 Dec;93(12):1021-7. doi: 10.1139/cjpp-2014-0353. Epub 2015 Sep 25.

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

Author information

1
a Laboratoire de Physiopathologie et Pharmacologies Cardio-Métaboliques (LPPCM), INSERM UMR866, Université de Bourgogne, Facultés de Médecine et de Pharmacie, 7 Boulevard Jeanne d'Arc, 21033 Dijon Cedex, France.
2
b Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, "UMF Iuliu Haţieganu", 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
3
c Department of Physiology, Faculty of Medicine, "UMF Iuliu Haţieganu" Cluj-Napoca, Romania.

Abstract

Diabetes is a chronic metabolic disease with a high prevalence worldwide. Diabetes and insulin resistance are associated with the development of cardiovascular and nervous diseases. The development of these disorders reflects complex pathological processes in which the oxidative stress caused by reactive oxygen species (ROS) and reactive nitrogen species (RNS) plays a pivotal role. It is widely accepted that diabetes impairs endothelial nitric oxide synthase (eNOS) activity and increases the production of ROS, thus resulting in diminished NO bioavailability and increased oxidative stress. Alpha-lipoic acid (LA) possesses beneficial effects both in the prevention and in the treatment of diabetes. LA is a potent antioxidant with insulin-mimetic and anti-inflammatory activity. LA in the diet is quickly absorbed, transported to the intracellular compartments, and reduced to dihydrolipoic acid (DHLA) under the action of enzymes. LA, which plays an essential role in mitochondrial bioenergetic reactions, has drawn considerable attention as an antioxidant for use in managing diabetic complications such as retinopathy, neuropathy and other vascular diseases.

KEYWORDS:

acide lipoïque; antioxidant; antioxydant; diabetes; diabètes; lipoic acid; metabolism; métabolisme; prevention; prévention; traitement; treatment

PMID:
26406389
DOI:
10.1139/cjpp-2014-0353
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center